Cargando…
Apixaban and eftrenonacog alfa treatment in a patient with moderate hemophilia B and cardiovascular disease
In developed countries, the life expectancy of patients with hemophilia (PwH) is now close to that of the unaffected male population. This means that these patients are at risk of developing age-related comorbidities, including cardiovascular disease. Managing cardiovascular disease in PwH patients...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
PAGEPress Publications, Pavia, Italy
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485731/ https://www.ncbi.nlm.nih.gov/pubmed/34667538 http://dx.doi.org/10.4081/hr.2021.9169 |